We are live on ! Find out more
OPK icon

Opko Health

175 hedge funds and large institutions have $735M invested in Opko Health in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 75 increasing their positions, 38 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

97% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 38

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

9% more capital invested

Capital invested by funds: $677M → $735M (+$58.4M)

4% more funds holding

Funds holding: 168175 (+7)

2.48% more ownership

Funds ownership: 17.62%20.11% (+2.5%)

49% less call options, than puts

Call options by funds: $63.2M | Put options by funds: $124M

Holders
175
Holders Change
+7
Holders Change %
+4.17%
% of All Funds
5.03%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.14%
New
19
Increased
75
Reduced
38
Closed
12
Calls
$63.2M
Puts
$124M
Net Calls
-$60.3M
Net Calls Change
-$28.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$112M -$410K -46,927 -0.4%
OHCM
2
Orchard Hill Capital Management
New York
$64.8M +$60M +6,865,900 +1,489%
BIT
3
BlackRock Institutional Trust
California
$50.6M -$204K -23,328 -0.4%
OIM
4
Oracle Investment Management
Connecticut
$50M +$732K +83,778 +2%
State Street
5
State Street
Massachusetts
$42.9M -$2.41M -276,351 -5%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$39.5M -$3.14M -359,900 -7%
BFA
7
BlackRock Fund Advisors
California
$38.8M -$3.25M -372,544 -8%
Morgan Stanley
8
Morgan Stanley
New York
$27.6M -$1.67M -190,759 -6%
MMH
9
Menora Mivtachim Holdings
Israel
$24.5M +$1.04M +119,509 +5%
Norges Bank
10
Norges Bank
Norway
$24.4M +$13.9M +1,592,010 +136%
Northern Trust
11
Northern Trust
Illinois
$20.5M -$2.57M -294,184 -11%
Goldman Sachs
12
Goldman Sachs
New York
$16.1M +$6.92M +793,017 +77%
LIA
13
LBMC Investment Advisors
Tennessee
$14.3M +$14.2M +1,622,341 New
Invesco
14
Invesco
Georgia
$12.3M +$9.18M +1,051,487 +314%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$10.7M -$2.08M -238,622 -16%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$10.6M +$422K +48,347 +4%
SM
17
Sabby Management
Florida
$10.6M +$3.17M +362,718 +44%
BL
18
Bolton LP
Connecticut
$10.5M +$7.86M +900,727 +314%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$8.71M -$16.5K -1,887 -0.2%
TCIM
20
TIAA CREF Investment Management
New York
$8.42M +$260K +29,740 +3%
Bank of America
21
Bank of America
North Carolina
$8.26M +$1.21M +139,022 +17%
GC
22
Guggenheim Capital
Illinois
$7.17M +$11.4K +1,306 +0.2%
Charles Schwab
23
Charles Schwab
California
$5.44M +$82.1K +9,400 +2%
CCA
24
Catalyst Capital Advisors
New York
$5.03M +$1.1M +125,748 +28%
Deutsche Bank
25
Deutsche Bank
Germany
$4.95M -$2.14M -245,144 -30%

OPK Hedge Fund Activity: Q2 2014 in Review

175 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q2 2014, worth a combined $735M — up 8.6% from $677M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new OPK positions and 12 closed out — a net gain of 7 holders — while 75 added to existing stakes and 38 trimmed.

The largest buyer was Orchard Hill Capital Management, adding an estimated $60M. The largest seller was Soros Fund Management, cutting an estimated $11M.

  • 175 institutional investors held Opko Health (OPK) as of Q2 2014, up from 168 in Q1 2014.
  • Funds reported $735M of Opko Health stock for Q2 2014, up 8.6% quarter-over-quarter.
  • 19 funds opened new Opko Health positions in Q2 2014 and 12 closed out, a net change of +7 holders.
  • The largest Opko Health buyer in Q2 2014 was Orchard Hill Capital Management, an estimated $60M added.
  • The largest Opko Health seller in Q2 2014 was Soros Fund Management, an estimated $11M sold.

Based on aggregated 13F filings for Q2 2014.